By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

A significant issue is under enrollment of women in randomized trials, meaning the percentage of women enrolled isn’t in line ...

A newly uncovered U.S. military report reveals that over 400 Japanese were mobilized to run the Class-B and C Yokohama war ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...

As part of the treatment trial, Jay does chemotherapy every other week for six months. Access to clinical trials is offered ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.